Wockhardt has received approval from the US Food & Drug Administration (US FDA) for marketing cefotaxime sodium injection in the US market. | |
| Cefotaxime sodium is the generic version of Sanofi Aventis' claforan injection and is a broad-spectrum antibiotic used in treating a wide variety of infections. The company's US subsidiary "� Wockhardt USA Inc "� will launch the cephalosporin antibiotic in the market within a few weeks. |
| |
| "This is our second approval for sterile cephalosporins, and our sixth approval in the last eight months," said Habil Khorakiwala, chairman, Wochardt group. |
| |
| Cefotaxime sodium is manufactured at the company's US FDA-certified sterile cephalosporin API (active pharmaceutical ingredient) facility at Ankleshwar and the injection is manufactured at the sterile formulation plant at Waluj. |
| |
| The processes for both API and the injection were developed in-house. |
| |
| Wockhardt currently markets 14 products in the US. |
| |
